27 February 2026

Directa Plus plc

("Directa Plus", the "Group" or the "Company")

Update on Funding and Board change

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, provides a further update following the Company's full year trading update announced on 7 January 2026.

The Board is in advanced discussions with its long-standing substantial shareholder, Nant Capital, LLC, with regards to the terms of a non-dilutive potential loan (the "Potential Loan"), with a principal amount of €4 million.

As previously announced, the Company will need to secure additional funding to support future growth plans, hence the discussions regarding the Potential Loan. In addition, and as also highlighted in the January trading update, the Board is evaluating its strategy for Setcar, with a focus on improving overall capital allocation and how best to maximise shareholder value. As part of this process, the Company has made initial progress regarding the potential sale of non-strategic land held by Setcar, with an estimated value of at least €0.5m. Setcar is continuing to implement its cost containment and cost reduction initiatives, including its workforce reduction programme, which is expected to be completed by mid-2026 reaffirming anticipated cost savings of approximately €0.5m for FY 2026.

The Italian company has also approved a number of costs reduction actions aimed at reducing yearly recurring costs by approximately €0.15m, with initial effect from April 2026.

Board update

Giorgio Bonfanti, the Company's Chief Financial Officer, has informed the Board of his intention to step down as a director of the Company, to pursue a new business opportunity, and will leave the Group at the end of March. The Board has commenced a recruitment process for a permanent replacement and in the meantime, a UK based finance professional with AIM experience will act as interim CFO.

Giulio Cesareo, Chief Executive Officer at Directa Plus, said: "I would like to thank Giorgio for his huge contribution to the Group over the past five years, including his support restructuring the business for its next phase of growth, and wish him all the very best for the future. I look forward to providing shareholders with an update on our discussions with Nant Capital, which to date have been very supportive."

Further updates will be provided in due course.

For further information, please contact:

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus's production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and past

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus's products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. The Company holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.